Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Xu

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Pharmacology|February 11, 2005
Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated hepatitis C infectionSanjee Aora, Christine Xu, Alice Teng, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 27, 2020
Population Pharmacodynamic Model of Neutrophil Margination and Tolerance to Describe Effect of Sarilumab on Absolute Neutrophil Count in Patients with Rheumatoid ArthritisPavel Kovalenko, Anne Paccaly, Anita Boyapati, et al.
Journal of Clinical Pharmacology|July 30, 2020
Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single-Dose Administration in Patients With Active Rheumatoid Arthritis on Stable MethotrexateAnne J Paccaly, Pavel Kovalenko, Janie Parrino, et al.
Clinical Pharmacology and Therapeutics|February 26, 2026
Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic EsophagitisJenny-Hoa Nguyen, Mirna Chehade, Evan S Dellon, et al.
The International Journal of Eating Disorders|May 3, 2020
Examining the self-reported advantages and disadvantages of socially networking about body image and eating disordersPatricia A Cavazos-Rehg, Ellen E Fitzsimmons-Craft, Melissa J Krauss, et al.
International Immunopharmacology|August 26, 2021
Dupilumab pharmacokinetics in Chinese healthy subjects and patients with atopic dermatitis: Results of two randomized, double-blind, placebo-controlled studiesPierre-François Clot, Mohamed Kamal, Jing Sun, et al.
Journal of Clinical Pharmacology|November 18, 2021
Pharmacokinetics and Concentration-Response of Dupilumab in Patients With Seasonal Allergic RhinitisMohamed A Kamal, Yoko Franchetti, Ching-Ha Lai, et al.
Clinical and Translational Science|August 20, 2022
Pharmacokinetics, pharmacodynamics, and exposure-efficacy of dupilumab in adults with atopic dermatitisMohamed A Kamal, John D Davis, Pavel Kovalenko, et al.
Rheumatology and Therapy|May 16, 2019
Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic DrugsAlvin F Wells, Janie Parrino, Erin K Mangan, et al.
Head & Neck|July 8, 2022
Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancerGhazal Haddad, Katrina Hueniken, Maria Christine Xu, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pharmacology|February 11, 2005
Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated hepatitis C infectionSanjee Aora, Christine Xu, Alice Teng, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 27, 2020
Population Pharmacodynamic Model of Neutrophil Margination and Tolerance to Describe Effect of Sarilumab on Absolute Neutrophil Count in Patients with Rheumatoid ArthritisPavel Kovalenko, Anne Paccaly, Anita Boyapati, et al.
Journal of Clinical Pharmacology|July 30, 2020
Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single-Dose Administration in Patients With Active Rheumatoid Arthritis on Stable MethotrexateAnne J Paccaly, Pavel Kovalenko, Janie Parrino, et al.
Clinical Pharmacology and Therapeutics|February 26, 2026
Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic EsophagitisJenny-Hoa Nguyen, Mirna Chehade, Evan S Dellon, et al.
The International Journal of Eating Disorders|May 3, 2020
Examining the self-reported advantages and disadvantages of socially networking about body image and eating disordersPatricia A Cavazos-Rehg, Ellen E Fitzsimmons-Craft, Melissa J Krauss, et al.
International Immunopharmacology|August 26, 2021
Dupilumab pharmacokinetics in Chinese healthy subjects and patients with atopic dermatitis: Results of two randomized, double-blind, placebo-controlled studiesPierre-François Clot, Mohamed Kamal, Jing Sun, et al.
Journal of Clinical Pharmacology|November 18, 2021
Pharmacokinetics and Concentration-Response of Dupilumab in Patients With Seasonal Allergic RhinitisMohamed A Kamal, Yoko Franchetti, Ching-Ha Lai, et al.
Clinical and Translational Science|August 20, 2022
Pharmacokinetics, pharmacodynamics, and exposure-efficacy of dupilumab in adults with atopic dermatitisMohamed A Kamal, John D Davis, Pavel Kovalenko, et al.
Rheumatology and Therapy|May 16, 2019
Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic DrugsAlvin F Wells, Janie Parrino, Erin K Mangan, et al.
Head & Neck|July 8, 2022
Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancerGhazal Haddad, Katrina Hueniken, Maria Christine Xu, et al.
Pageof 8